Florian van Bömmel

Professor of Medicine

University Hospital Leipzig

Germany

Research Interests

Explore related searches

Professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Florian van Bömmel is a Professor of Medicine at the University Hospital Leipzig, Germany. His research areas include hepatology, particularly focusing on chronic hepatitis B treatment, liver malignancies, and the clinical applications of biomarkers in liver diseases. Recent publications highlight his work on HBV dynamics, safety and efficacy of novel treatments, and innovative techniques in liver interventions.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Collaborators (18)

Manuel Struck

GERMANY

Florian van Bömmel

Research Interests

Explore related searches

Contact this professor

About

Articles (20)

Effects of Protamine Reversal on Coagulation Parameters After High-Dose Heparin Administration in Percutaneous Hepatic Chemosaturation Intervention

Dynamics of HBV biomarkers during nucleos(t)ide analog treatment: A 14-year study

Comparison of CT-Guided Microwave Ablation of Liver Malignancies with and Without Intra-Arterial Catheter Placement for Contrast Administration

Evaluation of four chatbots in autoimmune liver disease: A comparative analysis

JNJ-73763989 and bersacapavir treatment in nucleos(t)ide analogue-suppressed patients with chronic hepatitis B: REEF-2

Prospective Analysis of Safety and Efficacy of Tenofovir Alafenamide Fumarate (TAF) in European Real-World Patients with Chronic Hepatitis B: A Single-Centre Real-Word Cohort Study

Enhancing HCC recurrence prediction after liver transplantation: From DCP plus AFP-L3 model to GALAD score

Reply to: “A comment on `A multicenter randomized-controlled trial of nucleos(t)ide analogue cessation in HBeAg-negative chronic hepatitis B’”

Prognostic Factors for Postoperative Bleeding Complications and Prolonged Intensive Care after Percutaneous Hepatic Chemosaturation Procedures with Melphalan

A multicenter randomized-controlled trial of nucleos(t)ide analogue cessation in HBeAg-negative chronic hepatitis B

Confirmation of guideline defined hepatitis C screening strategies within the “ Check‐Up35 +” examination in the primary care setting

Anesthesiological and postinterventional management in percutaneous hepatic melphalan perfusion (chemosaturation),Anästhesiologisches und postinterventionelles Management bei perkutaner hepatischer Melphalanperfusion (Chemosaturation)

Chemosaturation of the Liver - an Update,Chemosaturation der Leber - ein Update

End-of-treatment HBsAg, HBcrAg and HBV RNA predict the risk of off-treatment ALT flares in chronic hepatitis B patients

Lower pretreatment HBV DNA levels are associated with better off-treatment outcomes after nucleo(s)tide analogue withdrawal in patients with HBeAg-neegative chronic hepatitis B: A multicentre cohort study

Treating hepatitis D with bulevirtide – Real-world experience from 114 patients

Clinical applications of circulating HBV RNA as a potential surrogate biomarker for intrahepatic cccDNA transcriptional activity

Analysis of Periprocedural X-ray Exposure in Transarterial Radioembolization with Glass or Resin Microspheres

Association of Common Polymorphisms in the Interleukin-1 Beta Gene with Hepatocellular Carcinoma in Caucasian Patients with Chronic Hepatitis B

Atezolizumab Plus Bevacizumab in Patients with Advanced and Progressing Hepatocellular Carcinoma: Retrospective Multicenter Experience

Collaborators (18)

Manuel Struck

Fabien Zoulim

Pietro Lampertico

Sebastian Krug

Johannes Wiegand

Milan J. Sonneveld

Jimmy Andres Daza Barragan

Timm Denecke

Nicole Erler

Holger Kirsten

Maria A. Gonzalez‐Carmona

Thomas Vanwolleghem

Marino Venerito

Thomas Berg

Osama Sabri

Silke Zimmermann

Niklas Sturm

Sebastian Ebel

Make your next move.